Sorting and cancer stem cell characteristic analysis of CD13<sup>+</sup>CD133<sup>+</sup>HCC cells in HuH7 cell line

您当前的位置：

首页 >

文章列表页 >

Sorting and cancer stem cell characteristic analysis of CD13⁺CD133⁺HCC cells in HuH7 cell line

更新时间：2026-01-09

- Sorting and cancer stem cell characteristic analysis of CD13⁺CD133⁺HCC cells in HuH7 cell line
- Journal of Army Medical University Vol. 34, Issue 16, Pages: 1658-1662(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R329-33;R730.23;R735.7
- Published：2012
- 稿件说明：
移动端阅览
金世龙,黄中荣,陈华,余天雾,曹洪,龙运全,周健,李鹤,苟毅,廖娟.HuH7细胞系CD13+CD133+HCC细胞分选及CSCs特性分析[J].陆军军医大学学报(原第三军医大学学报),2012,34(16):1658-1662.

　Jin Shilong,Huang Zhongrong,Chen Hua,Yu Tianwu,Cao Hong,Long Yunquan,Zhou Jian,Li He,Gou Yi,Liao Juan.Sorting and cancer stem cell characteristic analysis of CD13+CD133+HCC cells in HuH7 cell line[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(16):1658-1662.
金世龙,黄中荣,陈华,余天雾,曹洪,龙运全,周健,李鹤,苟毅,廖娟.HuH7细胞系CD13+CD133+HCC细胞分选及CSCs特性分析[J].陆军军医大学学报(原第三军医大学学报),2012,34(16):1658-1662. DOI：

　Jin Shilong,Huang Zhongrong,Chen Hua,Yu Tianwu,Cao Hong,Long Yunquan,Zhou Jian,Li He,Gou Yi,Liao Juan.Sorting and cancer stem cell characteristic analysis of CD13+CD133+HCC cells in HuH7 cell line[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(16):1658-1662. DOI：

摘要

目的探讨CD13、CD133双荧光标志流式细胞术（fluorescence activated cell sorter，FACS）分选人肝癌HuH7细胞系CD13

+

CD133

+

HCC细胞方法及癌干细胞（cancer stem cells，CSCs）特征。方法 CD13、CD133双标志，采用FACS从人肝癌HuH7细胞系分选出CD13

+

CD133

+

HCC、CD13

+

CD133

-

HCC、CD13

-

CD133

+

HCC、CD13

-

CD133

-

HCC等4种细胞亚群；通过CD13

+

CD133

+

HCC细胞生长曲线，细胞周期，形成肿瘤球和裸鼠体内成瘤能力，及对5-FU、吡柔比星化疗药物的敏感性研究，分析CD13

+

CD133

+

HCC细胞是否具有CSCs生物学特征。结果人肝癌HuH7细胞系CD13

+

CD133

+

HCC细胞占23.8%

3.1%分选为CD13

+

CD133

+

HCC细胞

78.45%的CD13

+

CD133

+

HCC细胞处于G

0

/G

1

期；CD13

+

CD133

+

HCC细胞增殖明显快于其他3个细胞亚群；在裸鼠10

3

个CD13

+

CD133

+

HCC细胞就可以成瘤，而1.0×10

5

个CD13

-

CD133

-

HCC只有2只成瘤(2/5)，干细胞培养CD13

+

CD133

+

HCC细胞8~15 d形成肿瘤球；CD13

+

CD133

+

HCC细胞对5-FU和吡柔比星具有抵抗特性，而其他3个亚群较易于杀灭。结论 CD13、CD133双标志FACS从HuH7分选的CD13

+

CD133

+

HCC细胞具有CSCs特征，可能成为HCC治疗靶细胞。

Abstract

Objective To study the sorting of CD13

+

CD133

+

HCC cell fraction in HuH7 cell line by fluorescence activated cell sorter (FACS) based on the expression of both CD13 and CD133 markers

and to analyze the cancer stem cells (CSCs) characteristics of CD13

+

CD133

+

HCC cells. Methods The antibodies against CD13 and CD133 were used as CSCs marker to sort CD13

+

CD133

+

HCC cells

CD13

+

CD133

-

HCC cells

CD13

-

CD133

+

HCC cells and CD13

-

CD133

-

HCC cells from HuH7 cell line by FACS. The growth curve

phase of cell cycle

sphere formation ability in vitro

tumor formation ability in vivo and susceptibility to 5-FU and pirarubicin of the CD13

+

CD133

+

HCC cells were investigated for CSCs identification and characterization of the CD13

+

CD133

+

HCC cells. Results The CD13

+

CD133

+

HCC cells accounted for 23.8% in HuH7 cell line

and 3.1% of the CD13

+

CD133

+

HCC cells was sorted as CSC-like cells. There was 78.45% of the CD13

+

CD133

+

HCC cells existed in G

1

/G

0

phase. The proliferating ability of the CD13

+

CD133

+

HCC cells was significantly stronger than that of the other cell subsets. The CD13

+

CD133

+

HCC cells could form a tumor in naked mice after 4 weeks with a number of 10

3

but 1.0×10

5

of the CD13

-

CD133

-

HCC cells were needed to form a tumor. The in vitro sphere formation of the CD13

+

CD133

+

HCC cells was observed after 8 to 15 d. The CD13

+

CD133

+

HCC cells had the chemo-resistant ability to 5-FU and pirarubicin

but the other cell subsets could be killed easily by these drugs. Conclusion The CD13

+

CD133

+

HCC cells sorted from HuH7 cell line by FACS bas

ed on the expression of both CD13 and CD133 markers have the characteristics of CSCs

and may be the therapeutic target for human hepatocellular carcinoma.

关键词

Keywords

references

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Related Articles

Failure to perform second-stage operation after first one of associating liver partition and portal vein ligation for staged hepatectomy: analysis of 62 cases

Mechanism of hepatitis B virus X inducing hepatocellular carcinoma in mice through COX-2 and its downstream factors

Combined detection and clinical pathological analysis of peripheral blood CK and CD133 in primary lung adenocarcinoma patients

Effects of 2-methoxyestradiol on proliferation, migration and radiosensitivity of nasopharyngeal carcinoma CNE-2 stem cells

Isolation and identification of cancer stem-like cells from lung cancer H1299 cells

Related Author

邓青松

何明莲

欧晏娇

冯凯

马宽生

张雷达

毋楠

周梦瑶

Related Institution

No data

⁰